Skip to main content
. 2009 Oct 29;285(3):1967–1979. doi: 10.1074/jbc.M109.038935

FIGURE 1.

FIGURE 1.

Diagram of mevalonate pathway and ApppI synthesis. Zoledronic acid acts by inhibiting FPP synthase. The mevalonate pathway is blocked, and the accumulation of IPP consequently occurs. Furthermore, IPP is conjugated to AMP to form a novel ATP analogue, ApppI.